Grants available for faculty at Canadian postsecondary institutions Deadline to submit application documents to International Engagement Unit: February 10, 2021 - directly to international.provost [at] mcgill.ca.
Countries worldwide face challenges meeting the growing needs for long-term care services because of high costs. A study led by researchers from McGill University and Université du Québec en Outaouais shows that introducing nurse practitioners can significantly reduce costs and improve patient safety.
A group of proteins called 4E-BPs, involved in memory formation, is the key to unlocking the antidepressant effect of ketamine in the brain, according to researchers from three Canadian universities. The discovery could lead to better and safer treatments for certain patients suffering from major depression.
Neural “signature” may reflect how we respond to feelings of social isolation
Researchers at McGill University are hopeful that the identification of the origin and a specific gene needed for tumour growth could lead to new therapeutics to treat a deadly brain cancer that arises in teens and young adults. The discovery relates to a subgroup of glioblastoma, a rare but aggressive form of cancer that typically proves fatal within three years of onset.
MONTREAL, QUEBEC – Pfizer Canada has made a $600,000 gift to the McGill Interdisciplinary Initiative in Infection and Immunity (MI4) via McGill University and the McGill University Health Centre (MUHC) Foundation. The gift, which was announced today during the 2nd annual MI4 Scientific Symposium, will support innovation and life-changing research through the creation of the Pfizer Early Career Investigator Awards.
Prof. Claire Brown receives Chan-Zuckerberg Initiative imaging scientist grant to advance bioimaging
Funding will support imaging technology, training and education at the Advanced BioImaging Facility (ABIF) at McGill
By Maureen McCarthy
Large multi-site study accurately predicts damage to grey matter by disease
An international study has found a link between the brain’s network connections and grey matter atrophy caused by certain types of epilepsy, a major step forward in our understanding of the disease.
Doctor has dedicated his life to improve diagnosis and treatment of neurological diseases and disorders
The Neuro’s director, Dr. Guy Rouleau, is being recognized with Canada’s highest civilian honour, the Order of Canada, for his outstanding contributions as a clinician-scientist and as a leader in health care.
By Meaghan Thurston (Office of Research and Innovation)
By Shawn Hayward
Six McGill University Faculty of Medicine and Health Sciences researchers — Boris Bernhardt, Mark Brandon, Yasser Iturria-Medina, Jean-Francois Poulin, Jo Anne Stratton and Masha Prager-Khoutorsky — have received grants to support their work in the early-career stage, after being chosen from 150 talented applicants.
Brain Canada program supports paradigm-shifting neuroscience that improves the lives of Canadians
Four researchers at The Neuro — Boris Bernhardt, Yasser Iturria-Medina, Jean-Francois Poulin, and Jo Anne Stratton — have received grants to support their work in the early-career stage, after being chosen from 150 talented applicants.
Five projects led by McGill University researchers are included among the 79 receiving a total of $28 million in research infrastructure support through the Canada Foundation for Innovation (CFI) Exceptional Opportunities Fund. The announcement was made today by the Honourable Navdeep Bains, Minister of Innovation, Science and Industry during a news conference this morning.
Earlier today, a Quebec based consortium of research institutes (Génome Québec, Oncopole and IVADO) announced the winners of their first-ever “Omics Data Against Cancer” competition, and McGill research teams were dominant. In fact, of the five selected teams no less than four of them included professors from McGill.
Earlier today, the Quebec government announced the winners of its annual Prix du Quebec competition, a series of 15 awards in science and culture. Among them was Professor William Foulkes, Head of the Cancer Genetics Laboratory at the Lady Davis Institute, a member of the Cancer Research Program of the Research Institute of the McGill University Health Centre, and Director of the Program in Cancer Genetics at McGill University. Dr.